Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bezard

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Experimental Neurology|March 11, 1999
Absence of MPTP-induced neuronal death in mice lacking the dopamine transporterE Bezard, C E Gross, M C Fournier, et al.
Neuroscience|May 6, 2008
Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in ratsE Y Pioli, W Meissner, R Sohr, et al.
CNS & Neurological Disorders Drug Targets|April 15, 2006
The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disordersP Sokoloff, J Diaz, B Le Foll, et al.
Neurobiology of Disease|February 3, 2005
L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brainE Bezard, C E Gross, Li Qin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2000
Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degenerationI Ghorayeb, P O Fernagut, I Aubert, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 3, 1999
Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkeyE Bezard, C Brefel, F Tison, et al.
Neuroscience|April 25, 2015
Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's diseaseC Fidalgo, W K D Ko, E Tronci, et al.
Neurobiology of Disease|September 3, 2005
Unraveling substantia nigra sequential gene expression in a progressive MPTP-lesioned macaque model of Parkinson's diseaseF Bassilana, N Mace, Q Li, et al.
Neuropharmacology|March 10, 2005
Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's diseaseP J Hallett, A W Dunah, P Ravenscroft, et al.
Gene Therapy|August 31, 2017
In utero delivery of rAAV2/9 induces neuronal expression of the transgene in the brain: towards new models of Parkinson's diseaseL Chansel-Debordeaux, M Bourdenx, S Dovero, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Experimental Neurology|March 11, 1999
Absence of MPTP-induced neuronal death in mice lacking the dopamine transporterE Bezard, C E Gross, M C Fournier, et al.
Neuroscience|May 6, 2008
Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in ratsE Y Pioli, W Meissner, R Sohr, et al.
CNS & Neurological Disorders Drug Targets|April 15, 2006
The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disordersP Sokoloff, J Diaz, B Le Foll, et al.
Neurobiology of Disease|February 3, 2005
L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brainE Bezard, C E Gross, Li Qin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2000
Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degenerationI Ghorayeb, P O Fernagut, I Aubert, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 3, 1999
Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkeyE Bezard, C Brefel, F Tison, et al.
Neuroscience|April 25, 2015
Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's diseaseC Fidalgo, W K D Ko, E Tronci, et al.
Neurobiology of Disease|September 3, 2005
Unraveling substantia nigra sequential gene expression in a progressive MPTP-lesioned macaque model of Parkinson's diseaseF Bassilana, N Mace, Q Li, et al.
Neuropharmacology|March 10, 2005
Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's diseaseP J Hallett, A W Dunah, P Ravenscroft, et al.
Gene Therapy|August 31, 2017
In utero delivery of rAAV2/9 induces neuronal expression of the transgene in the brain: towards new models of Parkinson's diseaseL Chansel-Debordeaux, M Bourdenx, S Dovero, et al.
Pageof 5